Results 1 to 10 of about 445,411 (238)

Hypoglycæmia in Neoplasia [PDF]

Postgraduate Medical Journal, 1963
Ellis Samols
openalex   +5 more sources

Shock and Neoplasia [PDF]

BMJ, 1951
H. N. Green, M. Savigear
openalex   +4 more sources

Multizonal anogenital neoplasia in women: a cohort analysis

BMC Cancer, 2021
Background There is currently a lack of information on full anogenital evaluation of women with a previous history of anogenital neoplasia. Methods Retrospective analysis of the Homerton Anogenital Neoplasia Service records from January 2012 to March ...
Andreia Albuquerque, Michelle A. L. Godfrey, Carmelina Cappello, Francesca Pesola, Julie Bowring, Tamzin Cuming, Anke De Masi, Adam N. Rosenthal, Peter Sasieni, Mayura Nathan   +9 more
doaj   +1 more source

The Role of TGF-β in Bone Metastases

Biomolecules, 2021
Complications associated with advanced cancer are a major clinical challenge and, if associated with bone metastases, worsen the prognosis and compromise the survival of the patients.
Trupti Trivedi, Gabriel M. Pagnotti, Theresa A. Guise, Khalid S. Mohammad   +3 more
doaj   +1 more source

Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells

Cell Death and Disease, 2023
Chimeric antigen receptor (CAR) T cell therapy is an FDA-approved treatment for several hematologic malignancies, yet not all patients respond to this treatment.
Alexandra L. Pourzia, Michael L. Olson, Stefanie R. Bailey, Angela C. Boroughs, Aditi Aryal, Jeremy Ryan, Marcela V. Maus, Anthony Letai   +7 more
doaj   +1 more source

Translational Strategies to Target Metastatic Bone Disease

Cells, 2022
Metastatic bone disease is a common and devastating complication to cancer, confounding treatments and recovery efforts and presenting a significant barrier to de-escalating the adverse outcomes associated with disease progression.
Gabriel M. Pagnotti, Trupti Trivedi, Khalid S. Mohammad   +2 more
doaj   +1 more source

3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations

Antibodies, 2022
Therapeutic monoclonal antibodies (mAbs) are an emerging and very active frontier in clinical oncology, with hundred molecules currently in use or being tested.
Virginia Guzzeloni, Lorenzo Veschini, Federica Pedica, Elisabetta Ferrero, Marina Ferrarini   +4 more
doaj   +1 more source

Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options

Endocrine Oncology, 2023
Adrenocortical carcinoma (ACC) is a rare cancer with high recurrence rates and heterogeneous clinical behavior. The role of adjuvant therapy remains unclear because of the challenges in collecting high-quality data for a rare cancer.
Ruaa Al-Ward, Celeste Zsembery, Mouhammed Amir Habra   +2 more
doaj   +1 more source

Parathyroid adenoma versus primary hyperparathyroidism [PDF]

Romanian Medical Journal, 2021
This is a narrative review of literature. We focus on the issue of identifying a parathyroid adenoma without anomalies of function (non-functioning parathyroid adenoma) which is incidentally detected or not, via routine neck ultrasound or through ...
Mihai Cristian Dumitrascu, Eugenia Petrova, Diana Elena Rentea, Stefania Zugravu, Adina Ghemigian, Mara Carsote, Anda Dumitrascu, Claudia Mehedintu, Florica Sandru   +8 more
doaj   +1 more source

Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer. [PDF]

, 2020
Background: Quantitative faecal immunochemical tests measure faecal haemoglobin concentration (f-Hb), which increases in the presence of colorectal neoplasia.Objective: We examined the diagnostic accuracy of faecal immunochemical test (FIT)in patients at
Cleary, Shirley, Datt, Pooja, Digby, Jayne, Fraser, Callum G., Goudie, David R., Gray, Lynne, Humphries, Adam, Mowat, Craig, Steele, Robert J. C., Strachan, Judith A.   +9 more
core   +2 more sources